About Us

CLSA Board of Directors



Wade Ackerman

Wade Ackerman

Partner, Covington & Burling LLP

William Annett

Chief Executive Officer OncoCyte

David Beier, J.D.

Managing Director, Bay City Capital

Fritz Bittenbender

Senior Vice President, Government Affairs, Genentech


Victoria H. Blatter

Senior Vice President, U.S. Government Affairs, Amgen

Josh Brown

Josh Brown

National Vice President, State Government Relations, Pfizer

David H. Crean

Managing Director & Partner, Objective Capital Partners

Mark Ginestro

Principal, Healthcare and Life Sciences, KPMG

bryan giraudo

Bryan Giraudo

Chief Financial Officer, Gossamer Bio


Elizabeth Grammer, Esq.

Executive Vice President, General Counsel and Head of Human Resources, Ardelyx, Inc.

jennifer johnson

Jennifer A. Johnson, Ph.D.

Associate General Counsel, DuPont Nutrition & Biosciences

Steve A. Kay, Ph.D., D.Sc.

Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California

Dirksen Lehman

Corporate Vice President, Public Affairs, Edwards Lifesciences


Casey Lynch

CEO, Co-founder, and Chairman, Cortexyme

John Maddalon

Principal, Life Science Practice, Deloitte

Sean McCarthy

President and Chief Executive Officer, CytomX


Grace Han McMahon

Head of Transactions, Pacific Innovation Hub, Business Development & Licensing, Merck Research Laboratories

Shlomo Melmed, MB, ChB, MACP

Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System

John Melo

Director, President and Chief Executive Officer, Amyris

Alan Mendelson

Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP

Jamey Millar

Senior Vice President, Managed Markets and Government Affairs, GlaxoSmithKline

Keith Murphy

Founder, CEO, and Chairman, Viscient Biosciences


William J. Newell

Chief Executive Officer, Sutro Biopharma, Inc.


John Nicols

President and Chief Executive Officer, Codexis

Chris Nolet

Christian W. Nolet


Joshua Ofman

Joshua J. Ofman, M.D., M.S.H.S

Chief of Corporate Strategy and External Affairs, Grail


Matthew Plunkett, Ph.D.

Senior Vice President & Chief Financial Officer, Nkarta Therapeutics


Stacey Pugh

Vice President and General Manager, Neurovascular, Medtronic

Ganesh Raman, Ph.D.

Associate Vice Chancellor for Research, California State University

Stephen Richardson

Stephen Richardson

Co-Chief Executive Officer, Alexandria Real Estate (ARE)

Wendye Robbins, MD

President & CEO, Blade Therapeutics

Beth Roberts

Partner, Hogan Lovells US LLP

Daria Mochly Rosen

Daria Mochly-Rosen, Ph.D.

The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine

Terry Rosen, Ph.D.

Chief Executive Officer, Arcus Biosciences

George Savage

George Savage M.D.

Co-Founder, Chief Medical Officer, Proteus Digital Health


Fran Schulz

Partner, Assurance Services – Life Sciences Practice, Ernst & Young

Paolo Simas

Paulo Simas

Chief Creative Officer, W20 Group


Lesley Stolz, Ph.D.

Managing Director, Lasana Partners


Mohit Trikha, Ph.D.

Vice President, Head of Oncology Early Development, AbbVie


Harold E. Van Wart, Ph.D.



Bridget Walsh

Vice-President, Government Affairs and Public Policy, Boehringer Ingelheim

Jared Watkin

Senior Vice President, Diabetes Care, Abbott

Rick E Winningham

Chairman and CEO, Theravance Biopharma